Literature DB >> 31712120

Mycoplasma pneumoniae-related hepatitis in children.

Dimitri Poddighe1.   

Abstract

Mycoplasma pneumoniae (M. pneumoniae) is a small bacterium characterized by the absence of cell wall. It is a human pathogen causing upper and lower respiratory infections, both in adults and children. However, it is also considered to be implicated in the pathogenesis of several types of extra-respiratory diseases, including some gastrointestinal disorders. The liver involvement in children during or after M. pneumoniae infections is analyzed and discussed in this review. Through a systematic literature search, it is evidenced that M. pneumoniae is not infrequently associated with alteration of liver function, but rarely causes acute and severe hepatitis in children. M. pneumoniae should be considered as an unusual cause of acute hepatitis in children, whenever the most common hepatotropic viruses have been excluded. The pathogenesis of M. pneumoniae-related hepatitis is likely to be immune-mediated: both the innate and adaptive immune responses may play a fundamental role. However, the exact pathological mechanisms have to be elucidated yet. Further clinical studies are needed in order to understand the actual relevance of this microorganism in liver disease and its pathogenesis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Cholestasis; Extra-pulmonary manifestations; Hepatitis; Immune-mediated disorders.; Mycoplasma pneumoniae

Year:  2019        PMID: 31712120     DOI: 10.1016/j.micpath.2019.103863

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.

Authors:  Chengchao Fang; Yueyan Mao; Mingfen Jiang; Wei Yin
Journal:  Front Surg       Date:  2022-05-25

2.  Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Xiang Li; Juan Wang; Qi Cheng; Yunxiao Shang; Guizhen Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

3.  Characteristics of Lung Microbiota in Children's Refractory Mycoplasma pneumoniae Pneumonia Coinfected with Human Adenovirus B.

Authors:  Wenxiang Zhou; Jinglong Chen; Zhimin Xi; Yanyan Shi; Libo Wang; Aizhen Lu
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-01-17       Impact factor: 2.471

4.  Kawasaki Disease With Combined Cholestatic Hepatitis and Mycoplasma pneumoniae Infection: A Case Report and Literature Review.

Authors:  Shen-Wen Huang; Sheng-Chieh Lin; Shih-Yen Chen; Kai-Sheng Hsieh
Journal:  Front Pediatr       Date:  2022-02-09       Impact factor: 3.418

Review 5.  Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: a case report and literature review.

Authors:  Wu Lei; Zhang Fei-Zhou; Chen Jing; Li Shu-Xian; Wu Xi-Ling; Tang Lan-Fang
Journal:  BMC Infect Dis       Date:  2022-02-23       Impact factor: 3.090

6.  Risk of Mycoplasma pneumoniae-related hepatitis in MP pneumonia pediatric patients: a predictive model construction and assessment.

Authors:  Yuna Bi; Yan Ma; Jinhua Zhuo; Lili Zhang; Liyan Yin; Hongling Sheng; Jie Luan; Tao Li
Journal:  BMC Pediatr       Date:  2021-06-21       Impact factor: 2.125

Review 7.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.